OCCURX
OccuRx, a Melbourne-based biopharmaceutical company, was established in 2014 with venture funding from the Medical Research Commercialisation Fund, Brandon Capital Partners and Uniseed. The Company’s primary focus is on the development of innovative therapeutic strategies for the treatment of ophthalmic disorders associated with retinal fibrosis.
OCCURX
Social Links:
Industry:
Biopharma Biotechnology Medical Therapeutics
Founded:
2014-01-01
Address:
Melbourne, Victoria, Australia
Country:
Australia
Website Url:
http://www.occurx.com
Total Employee:
11+
Status:
Active
Contact:
+61396570704
Email Addresses:
[email protected]
Total Funding:
5.19 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager Global Site Tag Nginx
Similar Organizations
AVEO Oncology
AVEO is a biopharmaceutical company that offers drug development strategies for targeted cancer therapeutics.
NephroDI Therapeutics
NephroDI Therapeutics is a biopharmaceutical company that focuses on the concentration disorders of the kidney.
Soligenix
Soligenix is a biopharmaceutical company that develops biodefense vaccines and therapeutics to treat rare diseases.
Spark Therapeutics
Spark Therapeutics is focused on the development of gene therapy.
Current Employees Featured
Founder
Investors List
Stoic VC
Stoic VC investment in Series A - OccuRx
Uniseed Ventures
Uniseed Ventures investment in Series A - OccuRx
Uniseed Ventures
Uniseed Ventures investment in Venture Round - OccuRx
Brandon Capital Partners
Brandon Capital Partners investment in Venture Round - OccuRx
Medical Research Commercialisation Fund (MRCF)
Medical Research Commercialisation Fund (MRCF) investment in Venture Round - OccuRx
Official Site Inspections
http://www.occurx.com Semrush global rank: 5.23 M Semrush visits lastest month: 1.56 K
- Host name: 170.64.249.143
- IP address: 170.64.249.143
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
